Company: ADPT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103752
Chunk: 52

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 52
---
 |             |    569,712 |   |     |      |  2,745,457 |   |     |             |  1,361,275 |   |     |      | (1,144,530 | ) |     |             | (2,584,615 | ) |     |      | (6,175,537 | ) |     |             | (3,112,380 | ) |     |      | 24,866,836 |   |     |             | 14,493,980 |   |

| (a) | Amounts in this row reflect the aggregate grant date fair value of RSUs, PSUs and options computed in accordance with ASC 718, rather than the amounts paid or realized by the named individual. We |

<div align='center'>41</div>

| 10-K |

| (3) | Peer group total shareholder return reflects the Nasdaq Biotechnology Index for all five fiscal years disclosed, which aligns with the peer group used in our Annual Report on Form10-Kfor each of these years. |

| (4) | Revenuewas chosen from the following three most important financial performance measures used by us to link compensation actually paid to the PEO andnon-PEONEOs in 2024 to the Company’s performance: |

| Performance Metrics |     |                                                                                   |
| Revenue             |     | Incentive Compensation and 2024 Goals Achievement                                 
 Compensation Discussion and Analysis-Elements of Executive Compensation           |
| Operating Expenses  |     | Incentive Compensation and 2024 Goals Achievement                                 
 Compensation Discussion and Analysis-Elements of Executive Compensation           |
| TSR                 |     | Establishing Target Equity Values and Equity Structure for our Executives         
 Compensation Discussion and Analysis-Executive Compensation Design and Philosophy |

Supplemental Graphs & Narratives Our compensation philosophy is to pay named executive officers for performance. To encourage our named executive officers to drive stock price performance, we pay more than 50% of total compensation in equity. The Compensation Actually Paid versus the TSR chart shows how compensation and our stock price have moved the same directionally over the past five years. The alignment between the compensation actually paid and TSR demonstrate that our compensation program is operating as intended. We believe consistent long-term growth in net income and revenue positively impacts our TSR performance over time and the value our named executive officers realize from their equity awards which can be seen in the growth from 2023 to 2024. Company TSR vs Peer Group